Sofac P 50 mg Tablet is a fixed-dose antiviral combination used for the treatment of chronic hepatitis C virus (HCV) infection. It generally contains: Sofosbuvir (50 mg) – a nucleotide analog polymerase inhibitor that blocks the HCV NS5B RNA-dependent RNA polymerase, preventing viral replication. Ledipasvir / Velpatasvir (low strength, depending on formulation) – an NS5A…
SOFVASC HCT 10/320/25MG TAB is a triple-combination medication used to treat high blood pressure (hypertension). It contains three active ingredients: amlodipine (10mg), valsartan (320mg), and hydrochlorothiazide (25mg). Amlodipine is a calcium channel blocker that relaxes blood vessels, valsartan is an angiotensin II receptor blocker (ARB) that prevents blood vessels from narrowing, and hydrochlorothiazide is a…
Sofvasc HCT is a triple-combination antihypertensive tablet containing: Amlodipine 5 mg – a calcium channel blocker that relaxes blood vessels. Valsartan 160 mg – an angiotensin II receptor blocker (ARB) that lowers blood pressure by preventing vasoconstriction. Hydrochlorothiazide (HCTZ) 25 mg – a thiazide diuretic that helps remove excess salt and water from the body,…
Select options
This product has multiple variants. The options may be chosen on the product page
SOFVASC V 5/160MG TAB is a combination medication used to treat high blood pressure (hypertension). It contains two active ingredients: amlodipine (5mg) and valsartan (160mg). Amlodipine is a calcium channel blocker that relaxes blood vessels, making it easier for the heart to pump. Valsartan is an angiotensin II receptor blocker (ARB) that works by preventing…
Sofvasc V 5/160mg Tablet combines amlodipine and valsartan, prescribed to manage high blood pressure. It helps relax blood vessels, improve blood flow, and reduce strain on the heart, thereby lowering the risk of heart attack, stroke, and other hypertension-related complications.
Sofvasc V 5/80mg Tablet is a combination of amlodipine and valsartan, used to treat high blood pressure. It works by relaxing blood vessels and reducing cardiac workload, helping control hypertension and lowering the risk of stroke, heart attack, and kidney damage.
Sofvasc V is a dual-combination antihypertensive tablet containing: Amlodipine 5 mg – a calcium channel blocker that relaxes blood vessels, improving blood flow and lowering blood pressure. Valsartan 80 mg – an angiotensin II receptor blocker (ARB) that prevents vasoconstriction and helps reduce blood pressure. This combination is prescribed for patients with high blood pressure…
Sofvasc V 5/80mg Tablet is a combination of amlodipine and valsartan, used to treat high blood pressure. It works by relaxing blood vessels and reducing cardiac workload, helping control hypertension and lowering the risk of stroke, heart attack, and kidney damage.
Solaris SC SPF40 is a broad-spectrum sunscreen that protects the skin from harmful UVA and UVB rays. It helps prevent sunburn, premature skin aging, and long-term sun damage, making it suitable for daily use. Its lightweight formula provides effective coverage without leaving a greasy residue.
Solaris Ultra 60+ is a high-protection sunscreen formulated to shield the skin from intense UVA and UVB rays. With SPF 60+, it helps prevent sunburn, pigmentation, and photoaging, making it ideal for sensitive or sun-exposed skin. Its lightweight texture ensures comfortable daily use without clogging pores.
Solfy 5 mg Tablet contains Solifenacin Succinate, a medicine used in the management of overactive bladder (OAB). It works by blocking muscarinic (M3) receptors in the bladder, thereby reducing involuntary bladder contractions. This helps improve symptoms such as: Frequent urination Urgency (sudden urge to urinate) Urge incontinence (involuntary leakage of urine) Uses: Overactive bladder (OAB)…
SOLIF 5MG TAB contains the active ingredient solifenacin succinate. It is a medication used to treat the symptoms of an overactive bladder. It works as a muscarinic receptor antagonist, which relaxes the bladder muscles, helping to reduce the frequent urge to urinate, urgency, and urinary incontinence (loss of bladder control). This allows the bladder to…
The Categories provide a framework to which existing art information systems can be mapped and upon which new systems can be developed. In addition, the discussions in the CDWA identify vocabulary resources and descriptive practices that will make information residing in diverse systems both more compatible and more accessible.The use of the CDWA framework will contribute to the integrity and longevity of data and will facilitate its inevitable migration to new systems as informational technology continues to evolve. Above all, it will help to give end-users consistent, reliable access to information, regardless of the system in which it resides.